Dietary pulverized konjac glucomannan suppresses scratching behavior and skin inflammatory immune responses in NC/Nga mice

International Archives of Allergy and Immunology

Volumn 144, Issue 2, 2007, Pages 95-104

  Onishi, Nobukazu ^a,c   Kawamoto, Seiji ^a   Suzuki, Hidenori ^b   Santo, Hiroyuki ^a   Aki, Tsunehiro ^a   Shigeta, Seiko ^a   Hashimoto, Kunihiko ^a   Hide, Michihiro ^b   Ono, Kazuhisa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Nishikawa Rubber Co Ltd   (Japan)

Author keywords

Atopic dermatitis; Konjac glucomannan; Mast cells; NC Nga mice; Scratching behavior; Skin immune response; Substance P

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; MANNAN; PULVERIZED KONJAC GLUCOMANNAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; HISTOPATHOLOGY; HYPERKERATOSIS; IMMUNE RESPONSE; MALE; MASTOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCRATCHING; SKIN ALLERGY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ANIMALS; DERMATITIS, ATOPIC; DIETARY CARBOHYDRATES; DISEASE MODELS, ANIMAL; EAR; EOSINOPHILIA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON-ALPHA; INTERLEUKIN-10; INTERLEUKIN-4; KERATOSIS; MALE; MANNANS; MASTOCYTOSIS, CUTANEOUS; MICE; MICE, INBRED STRAINS; PRURITUS; SKIN; SUBSTANCE P;

EID: 34548701353     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103220     Document Type: Article

References (34)

1. Doi K: Effect of konjac fibre (glucomannan) on glucose and lipids. Eur J Clin Nutr 1995;49(suppl 3):S190-S197.
2. Lim BO, Yamada K, Nonaka M, Kuramoto Y, Hung P, Sugano M: Dietary fibers modulate indices of intestinal immune function in rats. J Nutr 1997;127:663-667.
3. Yamada K, Tokunaga Y, Ikeda A, Ohkura K, Mamiya S, Kaku S, Sugano M, Tachibana H: Dietary effect of guar gum and its partially hydrolyzed product on the lipid metabolism and immune function of Sprague-Dawley rats. Biosci Biotechnol Biochem 1999;63:2163-2167.
4. Onishi N, Kawamoto S, Nishimura M, Nakano T, Aki T, Shigeta S, Shimizu H, Hashimoto K, Ono K: The ability of konjac-glucomannan to suppress spontaneously occurring dermatitis in NC/Nga mice depends upon the particle size. Biofactors 2004;21:163-166.
5. Onishi N, Kawamoto S, Nishimura M, Nakano T, Aki T, Shigeta S, Shimizu H, Hashimoto K, Ono K: A new immunomodulatory function of low-viscous konjac glucomannan with a small particle size: its oral intake suppresses spontaneously occurring dermatitis in NC/Nga mice. Int Arch Allergy Immunol 2005;136:258-265.
6. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C: Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-466.
7. Grewe M, Gyufko K, Schopf E, Krutmann J: Lesional expression of interferon-γ in atopic eczema. Lancet 1994;343:25-26.
8. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS: Roles of Th1 and Th2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999;103:1103-1111.
9. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA: New insights into atopic dermatitis. J Clin Invest 2004;113:651-657.
10. Oomizu S, Onishi N, Suzuki H, Ueda K, Mochizuki M, Morimoto K, Kawamoto S, Ono K, Kameyoshi Y, Hide M: Oral administration of pulverized konjac glucomannan prevents the increase of plasma immunoglobulin E and immunogloblin G levels induced by the injection of syngeneic keratinocyte extracts in BALB/c mice. Clin Exp Allergy 2006;36:102-110.
11. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS: Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998;101:1614-1622.
12. Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha RS: IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 2003;112:1058-1066.
13. Yamaguchi T, Maekawa T, Nishikawa Y, Nojima H, Kaneko M, Kawakita T, Miyamoto T, Kuraishi Y: Characterization of itch-associated response of NC mice with mite-induced chronic dermatitis. J Dermatol Sci 2001;25:20-28.
14. Arkwright PD, Fujisawa C, Tanaka A, Matsuda H: Mycobacterium vaccae reduces scratching behavior but not the rash in NC mice with eczema: a randomized, blinded, placebo-controlled trial. J Invest Dermatol 2005;124:140-143.
15. Mihara K, Kuratani K, Matsui T, Nakamura M, Yokota K: Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br J Dermatol 2004;151:335-345.
16. Ohmura T, Tsunenari I, Hayashi T, Satoh Y, Konomi A, Nanri H, Kawachi M, Morikawa M, Kadota T, Satoh H: Role of substance P in an NC/Nga mouse model of atopic dermatitis-like disease. Int Arch Allergy Immunol 2004;133:389-397.
17. Ohmura T, Hayashi T, Satoh Y, Konomi A, Jung B, Satoh H: Involvement of Substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 2004;491:191-194.
18. Sasakawa T, Higashi Y, Sakuma S, Hirayama Y, Sasakawa Y, Ohkubo Y, Goto T, Matsumoto M, Matsuda H: Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC/Nga mice. Int Arch Allergy Immunol 2001;126:239-247.
19. Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M: Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 2002;168:2020-2027.
20. Sakamoto T, Miyazaki E, Aramaki Y, Arima H, Takahashi M, Kato Y, Koga M, Tsuchiya S: Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice. Gene Ther 2004;11:317-324.
21. Morita E, Kaneko S, Hiragun T, Shindo H, Tanaka T, Furukawa T, Nobukiyo A, Yamamoto S: Fur mites induce dermatitis associated with IgE hyperproduction in an inbred strain of mice, NC/Kuj. J Dermatol Sci 1999;19:37-43.
22. Hashimoto Y, Arai I, Nakanishi Y, Sakurai T, Nakamura A, Nakaike S: Scratching of their skin by NC/Nga mice leads to development of dermatitis. Life Sci 2004;76:783-794.
23. Greaves MW, Wall PD: Pathophysiology of itching. Lancet 1996;348:938-940.
24. Watanabe N, Tomimori Y, Saito K, Miura K, Wada A, Tsudzuki M, Fukuda Y: Chymase inhibitor improves dermatitis in NC/Nga mice. Int Arch Allergy Immunol 2002;128:229-234.
25. Inagaki N, Nagao M, Igeta K, Kawasaki H, Kim JF, Nagai H: Scratching behavior in various strains of mice. Skin Pharmacol Appl Skin Physiol 2001;14:87-96.
26. Trautmann A, Akdis M, Kleemann D, Altznauer F, Simon HU, Graeve T, Noll M, Brocker EB, Blaser K, Akdis CA: T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000;106:25-35.
27. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, Mchugh T, Nassif AS, Chan SC, Modlin RL: Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995;154:1956-1963.
28. Enk AH, Katz SI: Identification and induction of keratinocyte-derived IL-10. J Immunol 1992;149:92-95.
29. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, Irimura T, Mizutani H, Matsushima K: Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999;104:1097-1105.
30. Uchida T, Suto H, Ra C, Ogawa H, Kobata T, Okumura K: Preferential expression of Th2 chemokine and its receptor in atopic dermatitis. Int Immunol 2002;14:1431-1438.
31. Vestergaard C, Kirstejn N, Gesser B, Mortensen JT, Matsushima K, Larsen CG: IL-10 augments the IFN-γ and TNF-α induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis. J Dermatol Sci 2001;26:46-54.
32. Nakamura H, Aoki M, Tamai K, Oishi M, Ogihara T, Kaneda Y, Morishita R: Prevention and regression of atopic dermatitis by ointment containing NF-κB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther 2002;9:1221-1229.
33. Gordon J, Galli S: Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI: a mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J Exp Med 1991;174:103-107.
34. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G: Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007;204:253-258.